A
Abdulsalam Alhalmi
Researcher at Jamia Hamdard
Publications - 18
Citations - 108
Abdulsalam Alhalmi is an academic researcher from Jamia Hamdard. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 2, co-authored 5 publications receiving 13 citations.
Papers
More filters
Journal ArticleDOI
Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation.
Mahfoozur Rahman,Waleed H. Almalki,Obaid Afzal,Abdulmalik Saleh Alfawaz Altamimi,Imran Kazmi,Fahad A. Al-Abbasi,Hani Choudhry,Sattam Khulaif Alenezi,Abul Barkat,Sarwar Beg,Vikas Kumar,Abdulsalam Alhalmi +11 more
TL;DR: Overall, the obtained results construed that RV-c-SLN with improved antitumor activity as clearly evident from in vitro, in vivo, and biochemical investigations.
Journal ArticleDOI
Recent progress in nanocarriers for direct nose to brain drug delivery
TL;DR: In this paper, a review summarizes advances of drug-loaded nanocarriers such as nanoemulsions, microemulsion, lipid nanoparticles, transfersomes, liposomes and polymeric micelles that have been reported for an effective nose to brain drug delivery and various methods to overcome the mucociliary clearance, the lower brain-blood ratio and the limited amount of the drug that can be incorporated which are the most common drawbacks for the nanoccarriers delivery via the nose to the brain.
Journal ArticleDOI
Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia.
TL;DR: In this article, the potential effects of medicinal plants and their derived lead molecules, and explains the related mechanisms and effects reviewed from published literature as major thrust aspects and hopeful strategies in the prevention or treatment of dementia.
Journal ArticleDOI
Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting.
TL;DR: The present review highlights the current focus on the application of nanocarrier systems using various ligand-based receptor-specific targeting strategies for the treatment and management of HCC.
Journal ArticleDOI
Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies
Abdulsalam Alhalmi,Saima Amin,Zafar Khan,Sarwar Beg,Omkulthom Al kamaly,Asmaa Saleh,Kanchan Kohli +6 more
TL;DR: These findings shed new light on how poorly soluble and poorly permeable medicines can be codelivered using NLCs in an oral nanoformulation to improve their medicinal performance.